Precipio
In Brief This Week: Myriad Genetics, Precipio, LumiraDx, Guardant Health, and More
News items for the in vitro diagnostics industry for the week of Jan. 18, 2021.
Precipio to Effect 1-for-15 Reverse Stock Split
The cancer diagnostics developer said it was undertaking the reverse stock split in order to meet the Nasdaq's $1 minimum bid price requirement.
In Brief This Week: BioDirection, Quest Diagnostics, OncoCyte, and More
A brief recap of Diagnostics news the week of Feb 15, 2019: SpeeDX, Translational Software, PWN Health & Allscripts Healthcare Solutions, Immunovia, Curculogene, Fujirebio Diagnostics, Precipio